FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092507 [Registered on: 06/08/2025] Trial Registered Prospectively
Last Modified On: 06/08/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   effect of Chandraprava Vati on prodromal symptoms of Madhumeha  
Scientific Title of Study   Evaluating the efficacy of Chandraprava Vati on purvarupa of Madhumeha(Prediabetes): An open label randomized clinical trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjib Kumar Das 
Designation  Associate Professor 
Affiliation  Affiliated to NCISM, Govt of India 
Address  Sri Sri College of Ayurvedic Science and Research Hospital Department of Kayachikitsa
Sri Sri University,Iconic Building, 3rd Floor Room No.309,Bidyadharpur, Cuttack, Odisha
Cuttack
ORISSA
754006
India 
Phone  09437292457  
Fax    
Email  ayursanjib@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjib Kumar Das 
Designation  Associate Professor 
Affiliation  Affiliated to NCISM, Govt of India 
Address  Sri Sri College of Ayurvedic Science and Research Hospital, Department of Kayachikitsa
Sri Sri University,Iconic Building, 3rd Floor Room No.309,Bidyadharpur, Cuttack, Odisha
Cuttack
ORISSA
754006
India 
Phone  09437292457  
Fax    
Email  ayursanjib@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjib Kumar Das 
Designation  Associate Professor 
Affiliation  Private 
Address  Sri Sri College of Ayurvedic Science and Research Hospital Department of Kayachikitsa
Sri Sri University,Iconic Building, 3rd Floor Room No.309,Bidyadharpur, Cuttack, Odisha
Cuttack
ORISSA
754006
India 
Phone  09437292457  
Fax    
Email  ayursanjib@gmail.com  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Dr Sanjib Kumar Das 
Address  Dr Sanjib Kumar Das, Sri Sri College of Ayurvedic Science and Research Hospital Department of Kayachikitsa, Sri Sri University,Iconic Building, 3rd Floor Room No.309,Bidyadharpur, Cuttack, Odisha 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanjib Kumar Das  Sri Sri Ayurveda Hospital  Sri Sri College of Ayurvedic Science and Research Hospital Department of Kayachikitsa Division- C Block Room No- C03 Odisha
Cuttack
ORISSA 
09437292457

ayursanjib@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Biomedical Research of Faculty of Health and Wellness Sri Sri College of Ayurvedic Science and Research Hospital Sri Sri University Cuttack 754006  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH, (2) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Chandraprava Vati , Reference: Vasava Rajeeyam Navamaprakaranam: Adhya - 9 Prameha, p-287 by Prof. (Dr) Gyanendra pandey Chowkhamba Krishnadas Academy, Varanasi – 201), Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -HONEY), Additional Information: -
2Comparator ArmLifestyle--Dinacarya: Wake up early (Brahma Muhurta 3o minutes brisk walking, Ritucarya: Not included, Acara Rasayana:Not Included, Other:, Pathya/Apathya:yes, Pathya:Fried yava yava sattu, old Sali – shsstika rice, Sidhu,Madhwika, Persons habitually taking roasted barley, dry corn, Millet, Oats, Apathya:Soubiraka, Tushodaka, Sukta, Sura, Asava, Ghrita, Dadhi, Ekshyu Vikara etc
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Fulfill prediabetes diagnostic criteria
HbA1c = 5.7-6.4%
Capable and willing of giving signed consent form
BMI (25-30) kg/m2
 
 
ExclusionCriteria 
Details  Patients with H/o prior use of medication to treat diabetes or diagnosed with diabetes
Newly diagnosed patients
Currently using oral hypoglycemic agents
Decompensated cardiac, kidney, hepatic failure, endocrine disorder.
Patients having used any medication for DM or pre diabetes in last 1 month.
Pregnant and lactating females.
Who have participated in any other study within 1 month before this study
conditions where there is an altered relationship between A1C and glycemia, such as; some hemoglobin variants, pregnancy (second and third trimesters and the postpartum period), glucose-6-phosphate dehydrogenase deficiency, HIV, hemodialysis, recent blood loss or transfusion, or erythropoietin therapy.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
HbA1c should be less than 5.7%  6 month of study 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of improvement in LFT, KFT, Lipid profile, CBC, HOMA-IR, HOMA-Beta,

Assessment of improvement in Pipasa, Karapada Daha/Suptata, Alasya), 
12 month of study 
 
Target Sample Size   Total Sample Size="176"
Sample Size from India="176" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Various studies conducted on prediabetic individuals for prevention of progression to diabetes which  include pharmacology therapy, yoga, life style modification. However ADR of pharmacolgy therapy and hurdles in long term sustainability of other interventions are found to be hurdles. Hence there is need of safe and effective remedies for its prevention which Ayurveda can do. 
Close